New insights from Clarivate examine strategic
partnerships, API production, and innovation in the region
LONDON, Feb. 27,
2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT)
a leading global provider of transformative intelligence, has
released a new white paper, How is Latin America Growing?,
shedding light on the pharmaceutical industry's evolution in the
region. The report explores critical challenges and opportunities,
emphasizing the importance of strategic partnerships, local API
production, and regulatory modernization to drive sustainable
growth.
Latin America's pharmaceutical
market, valued at $98 billion, is
projected to grow by 10.1% between 2021 and 20251.
Discussions at the 2023 Summit LATAM in Barcelona and the 2024 Summit LATAM at CPhI
Milan underscored the need for collaboration among industry
stakeholders, government agencies, and academia to strengthen
regional innovation and competitiveness. With increasing global
demand for pharmaceuticals, Latin
America has the potential to become a key player in the
industry by leveraging its manufacturing capabilities and investing
in research and development. Addressing regulatory challenges and
fostering a robust innovation ecosystem will be essential in
ensuring long-term success and sustainability for the region.
Henry Levy, President, Life
Sciences and Healthcare, Clarivate, said: "The Latin American
pharmaceutical sector is at a pivotal moment. By fostering
collaboration across key stakeholders—including regulators,
manufacturers, and researchers—we can unlock new opportunities for
growth and development in the region. Strengthening the local
pharmaceutical ecosystem through strategic partnerships and
data-driven insights will not only enhance supply chain resilience
but also ensure that life-changing therapies reach patients more
efficiently. At Clarivate, we are committed to providing the
necessary intelligence to support this transformation."
The Brazilian Pharmaceutical Industry Association
(ABIQUIFI), a non-profit organization uniting pharmaceutical
companies to advance the development and production of
pharmaceutical ingredients in Brazil, plays a pivotal role as a key partner
in these discussions. Norberto
Prestes, CEO, ABIQUIFI, stated, "The industry's
evolution in Latin America depends
on fostering transparency and trust in partnerships. By investing
in local API production and strengthening regional supply chains,
we can reduce dependency on external markets and drive economic
growth. Moreover, innovation and regulatory modernization are
crucial to positioning Latin
America as a competitive player in the global pharmaceutical
industry. These efforts will require sustained collaboration
between the public and private sectors, and we look forward to
continuing to lead these critical discussions. We'll continue
working closely with Clarivate to drive innovation, leveraging
valuable data to build the right path for sustainable growth and
advancement."
The report highlights key findings from recent discussions,
including:
- The need for greater transparency and collaboration in
strategic partnerships
- The potential of local API production to reduce reliance on
imports and enhance supply chain security
- The role of artificial intelligence in modernizing regulatory
processes and improving efficiency
- The importance of consistent, long-term policies to encourage
investment and innovation
Clarivate remains committed to supporting the region's life
sciences and healthcare sectors by providing reliable, data-driven
insights. By fostering industry-wide dialogue and collaboration,
the company aims to contribute to an ecosystem of sustainable
innovation in Latin America.
To access the full Clarivate report, How is Latin America
Growing?, visit here.
To learn more about how Clarivate can help healthcare companies
inform and shape the drug discovery, development and delivery
process, visit here.
About Clarivate
Clarivate is a leading global provider of transformative
intelligence. We offer enriched data, insights & analytics,
workflow solutions and expert services in the areas of Academia
& Government, Intellectual Property and Life Sciences &
Healthcare. For more information, please
visit www.clarivate.com
Media Contact:
Catherine
Daniel
Director External Communications, Life Sciences & Healthcare,
Clarivate
newsroom@clarivate.com
1 Source: InFigures: Latin
America 2022. Pharma Boardroom.
https://pharmaboardroom.com/country-reports/infigures-latin-america-2022/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/clarivate-report-explores-opportunities-for-innovation-and-market-expansion-in-latin-america-302386521.html
SOURCE Clarivate Plc
